美年健康
(002044)
| 流通市值：240.59亿 | | | 总市值：243.08亿 |
| 流通股本：38.74亿 | | | 总股本：39.14亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,925,390,135.63 | 4,109,252,112.57 | 1,754,077,010.26 | 10,701,990,901.1 |
| 营业收入 | 6,925,390,135.63 | 4,109,252,112.57 | 1,754,077,010.26 | 10,701,990,901.1 |
| 二、营业总成本 | 6,747,899,733.5 | 4,328,231,130.4 | 2,098,784,567.24 | 9,931,165,146 |
| 营业成本 | 4,270,857,332.19 | 2,751,824,853.47 | 1,332,388,282 | 6,123,339,473.89 |
| 税金及附加 | 4,083,846.66 | 3,114,393.34 | 1,577,678.94 | 7,667,178.16 |
| 销售费用 | 1,573,220,297.44 | 981,957,528.93 | 469,847,155.22 | 2,545,754,935.87 |
| 管理费用 | 633,221,283.2 | 414,756,912.62 | 208,131,402.48 | 884,622,864.45 |
| 研发费用 | 36,848,699.31 | 24,391,424.56 | 12,972,250.4 | 54,961,812.76 |
| 财务费用 | 229,668,274.7 | 152,186,017.48 | 73,867,798.2 | 314,818,880.87 |
| 其中:利息费用 | 232,089,210.08 | 154,026,447.32 | 76,356,784.7 | 319,374,299.01 |
| 其中:利息收入 | 8,320,533.46 | 6,528,209.29 | 4,062,380.17 | 12,665,539.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 32,496,984.97 | 5,834,933.43 | -50,297.45 | 4,410,783.15 |
| 加:投资收益 | 634,287.97 | -8,415,768.74 | -3,367,598.1 | 12,448,889.37 |
| 资产处置收益 | -8,508,996.83 | -3,131,248.98 | -2,753,410.11 | -8,491,372.66 |
| 资产减值损失(新) | - | - | - | -40,484,812.95 |
| 信用减值损失(新) | -55,427,748.88 | -19,094,924.46 | 9,984,502.75 | -148,036,901.89 |
| 其他收益 | 17,231,945.9 | 11,008,607.07 | 4,808,652.97 | 21,918,171.76 |
| 四、营业利润 | 163,916,875.26 | -232,777,419.51 | -336,085,706.92 | 612,590,511.88 |
| 加:营业外收入 | 4,626,884.09 | 3,669,641.3 | 1,513,878.78 | 7,961,387.13 |
| 减:营业外支出 | 30,216,263.55 | 18,918,273.2 | 6,381,031.55 | 28,034,259.97 |
| 五、利润总额 | 138,327,495.8 | -248,026,051.41 | -340,952,859.69 | 592,517,639.04 |
| 减:所得税费用 | 46,867,380.06 | -25,416,251.69 | -43,334,975.51 | 183,527,817.56 |
| 六、净利润 | 91,460,115.74 | -222,609,799.72 | -297,617,884.18 | 408,989,821.48 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 91,460,115.74 | -222,609,799.72 | -297,617,884.18 | 408,989,821.48 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 51,859,853.32 | -221,363,086.13 | -275,338,119.16 | 282,237,728.37 |
| 少数股东损益 | 39,600,262.42 | -1,246,713.59 | -22,279,765.02 | 126,752,093.11 |
| 扣除非经常损益后的净利润 | 12,228,899.05 | -238,330,324.71 | -282,322,715.31 | 252,253,354.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | -0.06 | -0.07 | 0.07 |
| (二)稀释每股收益 | 0.01 | -0.06 | -0.07 | 0.07 |
| 八、其他综合收益 | -116,396.64 | -48,028.29 | -16,587.45 | 202,657.93 |
| 归属于母公司股东的其他综合收益 | -17,533.88 | 40,630.94 | 4,639.57 | 58,659.65 |
| 九、综合收益总额 | 91,343,719.1 | -222,657,828.01 | -297,634,471.63 | 409,192,479.41 |
| 归属于母公司股东的综合收益总额 | 51,842,319.44 | -221,322,455.19 | -275,333,479.59 | 282,296,388.02 |
| 归属于少数股东的综合收益总额 | 39,501,399.66 | -1,335,372.82 | -22,300,992.04 | 126,896,091.39 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-30 | 2025-04-17 |
| 审计意见(境内) | | | | 标准无保留意见 |